What is OS Therapies's fair value adjustment of warrants?

OS Therapies (OSTX) reported fair value adjustment of warrants of -$302.04K in Q2 2025.

What does fair value adjustment of warrants mean?

Reflects the non-cash change in the valuation of outstanding warrants classified as liabilities. This adjustment is driven by market factors such as stock price volatility and the remaining term of the warrants.

OS Therapies OSTX Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

ImmunityBio, Inc.IBRX

$295.41M+65,840%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: OS Therapies’s 10-Q, filed August 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's fair value adjustment of warrants?: OS Therapies (OSTX) reported fair value adjustment of warrants of -$302.04K in Q2 2025.
What does fair value adjustment of warrants mean?: Reflects the non-cash change in the valuation of outstanding warrants classified as liabilities. This adjustment is driven by market factors such as stock price volatility and the remaining term of the warrants.